Latest News & Features
Big Pharma
The UK’s vote to leave the EU has triggered an immediate need for innovative life sciences companies to evaluate the impact on their patent strategies, argues Laetitia Benard of Allen & Overy. 30 June 2016
Biotechnology
Is it time for healthcare regulators and patent offices to limit the strategies used by existing biologic manufacturers and allow new suppliers to reach some of the world’s most lucrative healthcare systems? Elizabeth Ward of Virtuoso Legal investigates. 30 June 2016
Americas
BTG International and Janssen have sued Glenmark Pharmaceuticals claiming it has infringed a patent covering the Zytiga drug. 29 June 2016
Asia
Indonesian lawmakers have announced that hospitals and health clinics are being investigated by authorities after police exposed a group selling fake vaccines aimed at children for more than a decade. 29 June 2016
Big Pharma
Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses. 28 June 2016
Americas
The US Supreme Court announced yesterday that it has agreed to hear a patent infringement case between Promega and Life Technologies centring on DNA testing kits used to analyse genetic differences between people. 28 June 2016
Americas
The US Supreme Court has today made its decision to deny a review of the patent dispute between Sequenom and Ariosa Diagnostics over a patent covering pre-natal testing. 27 June 2016
Americas
UK-based diagnostics company Oxford Immunotec has announced that it will acquire Imugen, a US clinical laboratory, for $22.2 million in cash. 27 June 2016
Big Pharma
The European Patent Office has said that it expects a solution will be found to allow the implementation of the unitary patent despite the referendum result. 24 June 2016
Americas
Teva has settled its patent litigation dispute with AstraZeneca centring on diabetes drug Byetta. 24 June 2016